Hip/Knee Replacement System-Segmental Component(Limb Preservation System )
- UID
- IMP/MD/2019/000029_ecdf2296f596dfddfa432046a5a63e6f_fd673bd7a35a2bfeeb04fb33c5661ee0
- Device class
- Class D
- Brand name
- LPS
- License holder
- Johnson & Johnson Private Limited
- Approving authority
- CDSCO
- Product information
- The LPS System is intended for use in replacement of the mid-shaft portion of the femur, proximal, distal and/or total femur, and proximal tibia, especially in cases that require extensive resection and replacement. Specific diagnostic indications for use include: 1. malignant tumors (LPS) requiring extensive resection and replacement; 2. patient conditions of noninflammatory degenerative joint disease (LPS), e.g., avascular necrosis, osteoarthritis, and inflammatory joint disease (LPS), e.g., rheumatoid arthritis, requiring extensive resection and replacement; 3. revision cases for a failed previous prosthesis requiring extensive resection and replacement; 4. severe trauma requiring extensive resection and replacement. The LPS System is also intended for use in bone loss post-infection, where the surgeon has elected to excise the bone and replacement is required
Hip/Knee Replacement System-Segmental Component(Limb Preservation System ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2019/000029_ecdf2296f596dfddfa432046a5a63e6f_fd673bd7a35a2bfeeb04fb33c5661ee0. This device is marketed under the brand name LPS. The license holder is Johnson & Johnson Private Limited, and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.